Skip to main content
. 2022 Nov 11;101(45):e31713. doi: 10.1097/MD.0000000000031713

Table 2.

Comparison of patient characteristics according to fatigue severity scale and geriatric depression scale.

FSS GDS
Median (Minimum;Maximum) P-value Median (Minimum;Maximum) P-value
Sex Female 6.11 (1.1;9) <.0001** 16 (1;29) <.0001**
Male 4.6 (0.4;7) 10 (0;26)
Duration of diabetes (yr) ≤10 5.50 (0.4;7.5) <.0001** 12 (1;26) .001**
11–20 6 (2;7) 14 (0;29)
≥21 6.3 (3.8;9) 18 (1;28)
Age category (yr) 60–64 5.75 (0.4;9) .98 15 (1;25) .90
65–74 5.6 (2;7.5) 14 (0;29)
75–84 6.11 (1.1;7) 14.5 (1;24)
>85 5.6 (5.5;6) 14 (10;21)
Diabetes treatment OAD 5.45 (0.4;9) <.0001** 13.5 (1;29) .002**
OAD + basal insulin 4.3 (2.1;7) 10 (0;22)
Premixed insulin 6.3 (2;7) 17 (1;24)
Basal bolus insulin 6 (2;7) 15 (3;28)
BMI category 18.5–24.9 5.25 (1.1;7) .93 14 (0;26) .46
25–29.9 6 (4;7) 14 (1;28)
≥30 5.7 (2.1;9) 14 (1;29)
Social environment Living with family 5.2 (0.4;9) .038* 13 (0;28) .014*
Living alone 5.5 (1.1;7) 16.5 (3;29)
Smoke No 5.7 (0.4;9) .58 14 (0;29) .30
Yes 5.6 (2;7) 12 (1;26)
Vitamin D (ng/mL) <20 ng/mL 5.9 (1.1;9) .006** 14 (0;29) .92
≥20 ng/mL 4.6 (0.4;7) 15 (2;25)
Anemia Yes 6 (2;7) .196 15 (0;27) .39
No 5.65 (0.4;9) 14 (1;29)
Ferritin (ng/mL) <15 6.11 (2;7) .23 14 (4;29) .63
≥15 5.7 (0.4;9) 14 (0;28)
Vitamin B12 (pg/mL) <200 5.11 (2.2;7) .47 15 (1;29) .033*
200–299 6 (2;7.5) 13 (1;24)
≥300 5.7 (0.4;9) 11.5 (0;25)
LDL cholesterol (mg/dL) <100 5.6 (2;9) .53 14 (1;27) .82
≥100 5.8 (0.4;7.5) 14 (0;29)
Non-HDL cholesterol (mg/dL) <130 5.5 (2;7) .34 15 (1;27) .92
≥130 5.9 (0.4;9) 14 (0;29)
Triglyceride (mg/dL) <150 6 (0.4;9) .39 14 (1;29) .88
≥150 5.6 (2;7.5) 14 (0;28)

BMI = body mass index, HDL = high density lipoprotein, LDL = low density lipoprotein, OAD = oral antidiabetic drugs.

**P < .01, *P < .05.